Primary pre-B ALL cells treated with GZD824 alone showed much higher apoptotic levels than those cells treated with both GZD824 and IGF-1 (Figure 6B), suggesting that IGF-1 decreased the sensitivity of pre-B ALL cells to GZD824 treatment. The gene discussed is IGF1; the disease is acute lymphoblastic leukemia.